Impact of CAR T cell therapy in shifting the future peradigm of relapsed and refractory hematological cancer
| dc.code | 3632 | en_US |
| dc.contributor.author | Kundan, Ittu | |
| dc.date.accessioned | 2022-05-29T07:34:52Z | |
| dc.date.available | 2022-05-29T07:34:52Z | |
| dc.date.issued | 2019 | |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1228 | |
| dc.mentor | Dr. Vinay Tripathi | en_US |
| dc.organization | Mellata Meets,Delhi | en_US |
| dc.publisher | IIHMR Delhi | en_US |
| dc.publishyear | 2019-2021 | en_US |
| dc.subjectiihmr | Hospital Management | en_US |
| dc.title | Impact of CAR T cell therapy in shifting the future peradigm of relapsed and refractory hematological cancer | en_US |